Table 2.
Summary of medications received with 96 h of life.
| Dopamine treatment (cases), n = 18 | No dopamine treatment (controls), n = 36 | P-value | |
|---|---|---|---|
| Morphine, n (%) | 7 (39) | 16 (44) | 0.70 |
| Morphine, cumulative infusion dose, mcg/kg/h, mean ± SD | 541.1 ± 245 | 642.3 ± 337 | 0.45 |
| Fentanyl, n (%) | 12 (67) | 20 (56) | 0.43 |
| Fentanyl, cumulative infusion dose, mcg/kg/h, mean ± SD | 102.5 ± 32 | 63.1 ± 24.9 | <0.01a |
| Dexmedetomidine, n (%) | 1 (6) | 0 | 0.33 |
| Midazolam, n (%) | 4 (22) | 4 (11) | 0.42 |
| Vecuronium, n (%) | 0 | 0 | |
| Hydrocortisone, n (%) | 3 (17) | 0 | 0.03a |
| Phenobarbital, n (%) | 7 (39) | 9 (25) | 0.29 |
| Phenobarbital maintenance, n (%) | 3 (17) | 4 (11) | 1.00 |
| Fosphenytoin, n (%) | 1 (6) | 0 | 0.33 |
| Levetiracetam, n (%) | 1 (6) | 2 (6) | 1.00 |
| Levetiracetam maintenance, n (%) | 1 (6) | 2 (6) | 1.00 |
a
denotes significance at the p < 0.05 level.